Cargando…

The effect of magnesium alone or its combination with other supplements on the markers of inflammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): A systematic review

The objective of this systematic review is to synthesize the available evidence on the effectiveness of magnesium supplements on the markers of inflammation, oxidative stress (OS), and metabolism in PCOS patients and to provide a basis for its clinical treatment. Electronic databases (PubMed, Cochra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ruiyun, Li, Zhiyuan, Huang, Yi, Hu, Kaiyan, Ma, Bin, Yang, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389579/ https://www.ncbi.nlm.nih.gov/pubmed/35992132 http://dx.doi.org/10.3389/fendo.2022.974042

Ejemplares similares

Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management
por: Wang, Yishu, et al.
Publicado: (2022)

MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
por: Cirillo, Francesca, et al.
Publicado: (2019)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

An Improved Dehydroepiandrosterone-Induced Rat Model of Polycystic Ovary Syndrome (PCOS): Post-pubertal Improve PCOS's Features
por: Kim, Eun-Jeong, et al.
Publicado: (2018)

Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review
por: Sangaraju, Sai Lahari, et al.
Publicado: (2022)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
por: Ganie, Mohd Ashraf, et al.
Publicado: (2019)

Association between pediatric asthma and adult polycystic ovarian syndrome (PCOS): a cross-sectional analysis of the UAE healthy future Study (UAEHFS)
por: Juber, Nirmin F., et al.
Publicado: (2023)

Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS)
por: Hadidi, Mahta, et al.
Publicado: (2023)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review
por: Kanda, Srishti, et al.
Publicado: (2023)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
por: Li, Youran, et al.
Publicado: (2022)

Probable discrepancy in the prevalence of polycystic ovarian syndrome (PCOS)
por: Javed, Haseeba, et al.
Publicado: (2022)

Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study
por: Elghobashy, Mirna, et al.
Publicado: (2023)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

Efficacy of combined metformin–clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS)
por: Ayaz, A, et al.
Publicado: (2013)

Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome
por: Al-Hail, Noora, et al.
Publicado: (2019)

“PCOS is Like having a Disease”: The Everyday Stress of Living with Polycystic Ovarian Syndrome (PCOS)
por: Divya, M, et al.
Publicado: (2022)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

Polycystic Ovarian Syndrome (PCOS): Does the Challenge End at Conception?
por: Mirza, Fadi G., et al.
Publicado: (2022)

Naturopathic live food model in polycystic ovarian syndrome (PCOS)
por: Venugopal, Vijayakumar, et al.
Publicado: (2022)

Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology
por: Liao, Baoying, et al.
Publicado: (2021)

Circulating bile acid profile characteristics in PCOS patients and the role of bile acids in predicting the pathogenesis of PCOS
por: Yu, Jie, et al.
Publicado: (2023)

Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS
por: Daghestani, Mazin H., et al.
Publicado: (2021)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

FRI458 Rare Pathogenic Missense Variants in LMNA Identified in Women with Polycystic Ovary Syndrome (PCOS)
por: Bauer, Rosemary, et al.
Publicado: (2023)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

Association between HOMA-IR and ovarian sensitivity index in women with PCOS undergoing ART: A retrospective cohort study
por: Li, Yan, et al.
Publicado: (2023)

SUN-011 Beyond PCOS - Ovarian Neoplasms Presenting with Hirsutism and Virilization
por: Chakravorty, Shourjo, et al.
Publicado: (2020)

Posttranslational modifications in pathogenesis of PCOS
por: Wei, Huimei, et al.
Publicado: (2022)

Top 100 #PCOS influencers: Understanding who, why and how online content for PCOS is influenced
por: Elhariry, Maiar, et al.
Publicado: (2022)

Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota
por: Wang, Xuejiao, et al.
Publicado: (2022)

Role of Androgen Receptor for Reconsidering the “True” Polycystic Ovarian Morphology in PCOS
por: Gao, Xue-ying, et al.
Publicado: (2020)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6i3be51ob0fbav66s3pdcfsmfm